You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

eganelisib

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors (Part A/B/C/D), NSCLC (Part E), Melanoma (Part E) Trial in United States (IPI-549 (eganelisib), Nivolumab)

Active, not recruiting
  • Advanced Solid Tumors (Part A/B/C/D)
  • +7 more
  • San Diego, California
  • +10 more
Apr 1, 2022

Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

Active, not recruiting
  • Bladder Cancer
  • +3 more
  • IPI-549 (eganelisib)
  • +2 more
  • Fort Wayne, Indiana
  • +28 more
Apr 1, 2022

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022